CAM
SRNE

ClariVest Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

ClariVest Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-162
Closed – – 775
2022
Q2 		$0 Sell
162
-12,000
-99% -$20.7K ﹤0.01% 805
2022
Q1 		$28K Sell
12,162
-53,502
-81% -$167K ﹤0.01% 454
2021
Q4 		$306K Sell
65,664
-3,197
-5% -$19.8K 0.01% 465
2021
Q3 		$526K Sell
68,861
-2,368
-3% -$20.1K 0.02% 433
2021
Q2 		$691K Sell
71,229
-58,835
-45% -$469K 0.02% 372
2021
Q1 		$1.07M Buy
130,064
+8,862
+7% +$93.6K 0.04% 276
2020
Q4 		$828K Sell
121,202
-75,553
-38% -$607K 0.03% 296
2020
Q3 		$2.19M Buy
+196,755
New +$1.8M 0.07% 209

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return